Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nirjal Bhattarai

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Methods and Protocols|September 22, 2025
A Scalable Protocol for Ex Vivo Production of CAR-Engineered Human NK CellsSupreet Khanal, Nirjal Bhattarai
Frontiers in Immunology|July 5, 2021
CAR-T Cell Therapy: Mechanism, Management, and Mitigation of Inflammatory ToxicitiesJoseph W Fischer, Nirjal Bhattarai
Trends in Microbiology|February 14, 2012
GB virus C: the good boy virus?Nirjal Bhattarai, Jack T Stapleton
Cytotherapy|June 27, 2025
Feeder cell-free production of CAR-NK cells via activation of PKC and calcium signaling pathwaysSupreet Khanal, Alan Baer, Nirjal Bhattarai
Scientific Reports|July 21, 2018
Characterization of the effects of immunomodulatory drug fingolimod (FTY720) on human T cell receptor signaling pathwaysAlan Baer, Winston Colon-Moran, Nirjal Bhattarai
Antiviral Therapy|September 7, 2012
GB virus C infection is associated with a reduced rate of reactivation of latent HIV and protection against activation-induced T-cell deathRobert T Rydze, Nirjal Bhattarai, Jack T Stapleton
Plos One|October 27, 2017
Src-family kinases negatively regulate NFAT signaling in resting human T cellsAlan Baer, Winston Colon-Moran, Jinhua Xiang, et al.
The Journal of Infectious Diseases|August 29, 2012
GB virus C viremia is associated with higher levels of double-negative T cells and lower T-cell activation in HIV-infected individuals receiving antiretroviral therapyNirjal Bhattarai, Robert T Rydze, Ernest T Chivero, et al.
Virology|August 7, 2015
Human Pegivirus (HPgV; formerly known as GBV-C) inhibits IL-12 dependent natural killer cell functionErnest T Chivero, Nirjal Bhattarai, James H McLinden, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|November 21, 2021
TCR-independent Activation in Presence of a Src-family Kinase Inhibitor Improves CAR-T Cell Product AttributesGauri Lamture, Alan Baer, Joseph W Fischer, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Methods and Protocols|September 22, 2025
A Scalable Protocol for Ex Vivo Production of CAR-Engineered Human NK CellsSupreet Khanal, Nirjal Bhattarai
Frontiers in Immunology|July 5, 2021
CAR-T Cell Therapy: Mechanism, Management, and Mitigation of Inflammatory ToxicitiesJoseph W Fischer, Nirjal Bhattarai
Trends in Microbiology|February 14, 2012
GB virus C: the good boy virus?Nirjal Bhattarai, Jack T Stapleton
Cytotherapy|June 27, 2025
Feeder cell-free production of CAR-NK cells via activation of PKC and calcium signaling pathwaysSupreet Khanal, Alan Baer, Nirjal Bhattarai
Scientific Reports|July 21, 2018
Characterization of the effects of immunomodulatory drug fingolimod (FTY720) on human T cell receptor signaling pathwaysAlan Baer, Winston Colon-Moran, Nirjal Bhattarai
Antiviral Therapy|September 7, 2012
GB virus C infection is associated with a reduced rate of reactivation of latent HIV and protection against activation-induced T-cell deathRobert T Rydze, Nirjal Bhattarai, Jack T Stapleton
Plos One|October 27, 2017
Src-family kinases negatively regulate NFAT signaling in resting human T cellsAlan Baer, Winston Colon-Moran, Jinhua Xiang, et al.
The Journal of Infectious Diseases|August 29, 2012
GB virus C viremia is associated with higher levels of double-negative T cells and lower T-cell activation in HIV-infected individuals receiving antiretroviral therapyNirjal Bhattarai, Robert T Rydze, Ernest T Chivero, et al.
Virology|August 7, 2015
Human Pegivirus (HPgV; formerly known as GBV-C) inhibits IL-12 dependent natural killer cell functionErnest T Chivero, Nirjal Bhattarai, James H McLinden, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|November 21, 2021
TCR-independent Activation in Presence of a Src-family Kinase Inhibitor Improves CAR-T Cell Product AttributesGauri Lamture, Alan Baer, Joseph W Fischer, et al.
Pageof 3